超低剂量运动首过心肌灌注SPECT常规报告的真实世界评估及其与后续造影冠状动脉狭窄报告的相关性
本研究基于11,952例患者的13,126份常规运动心肌灌注SPECT报告,评估超低剂量运动首过方案的常规报告情况。中位有效剂量2.51 mSv,正常率98%,MPI缺血独立预测因素包括已知CAD、男性、肥胖和LVEF<50%。MPI缺血显著预测后续造影>50%冠状动脉狭窄,中重度缺血预测更强。
要点
- 超低剂量运动首过MPI中位有效剂量2.51 mSv,正常率98%。
- MPI缺血独立预测因素为已知CAD、男性、肥胖和LVEF<50%。
- MPI缺血显著预测后续造影>50%狭窄,中重度缺血预测更强。
核心结论
- 在大规模真实世界临床队列中,超低剂量运动首过MPI方案检出的缺血是后续造影报告冠状动脉狭窄的高度显著预测因素。
- 该预测受其他变量增强。
- 这种低照射方法适合在高MPI缺血概率的目标患者群体中以更短时间间隔重复。
研究设计与样本
- 研究提取11,952例患者(31%女性)的13,126份常规运动MPI报告,使用超低剂量sestamibi和高灵敏度心脏CZT相机。
- 评估显著MPI缺血(>1个左心室节段)的报告情况。
- 在CAD验前概率<5%组(n=378)中确定MPI正常率。
- 评估MPI对MPI后3个月内可获取冠状动脉造影报告患者(n=713)中>50%冠状动脉狭窄的预测能力。
主要发现
- 中位有效患者剂量为2.51 mSv(IQR:1.00-4.71)。
- 正常率为98%。
- MPI缺血率由已知CAD、男性、肥胖和LVEF<50%独立预测,从所有危险因素均具备时的29.5%到无危险因素时的1.5%。
- >50%冠状动脉狭窄由MPI缺血显著预测,轻度MPI缺血的比值比(95%CI)为1.61(1.26-1.96),中重度MPI缺血为4.05(3.53-4.57)。
- >50%冠状动脉狭窄还受已知CAD(2.17[1.83-2.51])、次极量运动试验(1.48[1.15-1.81])和年龄≥65岁(1.43[1.11-1.76])影响。
关键数值与推荐
- 显著MPI缺血定义为>1个左心室节段。
- CAD验前概率<5%组(n=378)用于确定MPI正常率(98%)。
- MPI后3个月内可获取冠状动脉造影报告的患者(n=713)用于评估MPI对>50%冠状动脉狭窄的预测。
临床怎么用
- 超低剂量运动首过MPI方案可用于常规临床报告,检出的缺血可预测后续造影冠状动脉狭窄。
- 已知CAD、男性、肥胖和LVEF<50%患者MPI缺血率较高,解读时应考虑这些因素。
- 该低照射方法适合在高MPI缺血概率目标患者群体中以更短时间间隔重复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our study assesses the routine reporting of exercise ischemia using very low-dose exercise-first myocardial perfusion SPECT in a large number of patients and under real-life conditions, by evaluating correlations with the subsequent routine reporting of coronary stenosis by angiography and with factors that predict ischemia. METHODS: Data from 13,126 routine exercise MPI reports, from 11,952 patients (31% women), using very low doses of sestamibi and a high-sensitivity cardiac CZT camera, were extracted to assess the reporting of significant MPI-ischemia (> 1 left ventricular segment), to determine the MPI normalcy rate in a group with < 5% pretest probability of coronary artery disease (CAD) (n = 378), and to assess the ability of MPI to predict a > 50% coronary stenosis in patients with available coronary angiography reports in the 3 months after the MPI (n = 713). RESULTS: The median effective patient dose was 2.51 [IQR: 1.00-4.71] mSv. The normalcy rate was 98%, and the MPI-ischemia rate was independently predicted by a known CAD, the male gender, obesity, and a < 50% LV ejection fraction, ranging from 29.5% with all these risk factors represented to 1.5% when there were no risk factors. A > 50% coronary stenosis was significantly predicted by MPI-ischemia, less significantly for mild (odds ratio [95% confidence interval]: 1.61 [1.26-1.96]) than for moderate-to-severe MPI-ischemia (4.05 [3.53-4.57]) and was also impacted by having a known CAD (2.17 [1.83-2.51]), by a submaximal exercise test (1.48 [1.15-1.81]) and being ≥ 65 years of age (1.43 [1.11-1.76]). CONCLUSION: Ischemia detected using a very low-dose exercise-first MPI protocol in a large-scale clinical cohort and under real-life routine conditions is a highly significant predictor for the subsequent reporting of coronary stenosis, although this prediction is enhanced by other variables. This weakly irradiating approach is amenable to being repeated at shorter time intervals, in target patient groups with a high probability of MPI-ischemia.
引用
- Chawki MB, Goncalves T, Boursier C, et al. Assessment of the routine reporting of very low-dose exercise-first myocardial perfusion SPECT from a large-scale real-world cohort and correlation with the subsequent reporting of coronary stenosis at angiography. Eur J Nucl Med Mol Imaging. 2021. PMID: 34655307. doi:10.1007/s00259-021-05575-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。